RESEARCH-USE BIOSIMILAR ANTIBODY
Lerdelimumab
Monoclonal antibody · IgG4
Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research.
TARGETTGFB1
YMonoclonal antibody
CATALOGSC-BS-441
CATALOG NUMBERSC-BS-441
MOLECULAR WEIGHTLot-specific
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research.
Lerdelimumab is a recombinant research-use antibody directed against TGFB1.